GGrantIndex
← Search

CCTN - MALE CONTRACEPTIVE TRIAL DMAU-SEDDS STUDY

$527,985N01FY2016HDNIH

University Of Washington, Seattle WA

Investigators

Abstract

Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man. Male Contraceptive Trial DMAU with Self-Emulsifying Drug Delivery System (SEDDS) Study

View original record on NIH RePORTER →